REACH
REACH 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Asthma (Diagnosis)。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
2 项
已进入 III/IV 期
14 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Washington University School of Medicine
- Assistance Publique - Hôpitaux de Paris
- Ibadat International University, Islamabad
- University of Bergen
- Institute of Hematology & Blood Diseases Hospital, China
- Universitair Ziekenhuis Brussel
- Seoul National University Hospital
- Southwest Autism Research & Resource Center
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
法国、Pakistan、挪威、中国、比利时、South Korea、美国、意大利、Uganda、英国、西班牙、Turkey (Türkiye)
正在招募患者的 REACH 研究
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
IV 期招募中法国NCT02472028Comparison of Sensory Integration Therapy and Conventional Physical Therapy on Gross Motor Function in Children With Athetoid Cerebral Palsy: A Randomized Controlled Trial
不适用招募中PakistanNCT07611565Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled Study
不适用招募中挪威NCT07028450Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
不适用招募中中国NCT06529250Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
不适用招募中比利时NCT07029152Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
不适用招募中South KoreaNCT06649240Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults
II 期招募中美国NCT06526208Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism
不适用招募中意大利NCT07389720Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis
不适用招募中挪威NCT07530588Flexible Reaching Control in Parkinson Disease
不适用招募中比利时NCT05908266Linking Somatic Mutation Rate With Baseline Exposure in East Palestine
不适用招募中美国NCT06357845Call for Life Sepsis
不适用招募中UgandaNCT07407868ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
II 期招募中美国中国NCT04986423Implementation Pilot of Preoperative CGA Before Major Surgery
不适用招募中美国NCT06184724Cellulitis Optimal Antibiotic Treatment
III 期招募中英国NCT05584007Mechanical Insufflation-Exsufflation in Critically Ill Patients
不适用招募中意大利西班牙Turkey (Türkiye)NCT07420946Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
II 期招募中法国NCT03364530Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism
不适用招募中EgyptNCT06041204Effectiveness of Exercise After an ICD
不适用招募中美国NCT03544489Neural Mechanisms of Response Inhibition Training for OCRD
不适用招募中美国NCT05377125Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
II 期招募中美国NCT05446584Mountain West Prevention Research Center Core Research Project
不适用招募中美国NCT07479498Toripalimab Combined With Definitive CCRT for LACC Patients
不适用招募中中国NCT06256224Severe COVID-19 Infection in Children Presenting to EDs in Israel and England
不适用招募中IsraelNCT06434701
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。